Ask Stephen Hughes, Ph.D., to explain his work, and he’ll tell you about teamwork. He sees it as more than just the ubiquitous status quo in science: it is the philosophy that has defined his nearly 35-year career at NCI at Frederick.

According to the Centers for Disease Control and Prevention (CDC), antibiotic-resistant bacteria are one of the greatest threats to public health today. While antibiotics are very helpful, they can also be misused, which is one of the reasons resistance has become such a problem.

Nipah virus is a zoonotic virus that is responsible for multiple outbreaks across Asia, including in Malaysia, Singapore, and India. The virus has been added to the World Health Organization’s 2018 Priority Diseases List, which indicates a pressing need for further research and development.

In a ceremony held in the Building 1520 auditorium on June 28, Col. Michael Sauer, U.S. Army Medical Research and Materiel Command, Operations, distributed the awards for outstanding presentations and posters at the 2018 Spring Research Festival.

During an address to the recent annual meeting of the American Society of Clinical Oncology, NCI Director Norman “Ned” Sharpless, M.D., announced that the National Cancer Institute is committing $10 million to support NCI-run clinical trials this year. The funds, which will be given in addition to the normal budget, are dedicated to trials conducted within the NCI Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program.